Verster, Joris C. https://orcid.org/0000-0002-6455-2096
Scholey, Andrew
Dahl, Thomas A.
Iversen, Jacqueline M.
Funding for this research was provided by:
Sen-Jam Pharmaceutical
Article History
Received: 29 June 2020
Accepted: 21 January 2021
First Online: 8 February 2021
Declarations
:
: Over the past 36 months, A.S. has held research grants from Abbott Nutrition, Arla Foods, Bayer, BioRevive, DuPont, Fonterra, Kemin Foods, Nestlé, Nutricia-Danone, and Verdure Sciences. He has acted as a consultant/expert advisor to Arepa Nootroptics, Bayer, Coca-Cola, Danone, Naturex, Nestlé, Pfizer, Sanofi, and Sen-Jam Pharmaceutical, and has received travel/hospitality/speaker fees from Bayer, Sanofi, and Verdure Sciences. Over the past 36 months, J.C.V. has held grants from Janssenand Sequential Medicine, and acted as a consultant/expert advisor to More Labs, Red Bull, Sen-Jam Pharmaceutical, Toast!, Tomo, and ZBiotics. J.M.I. is the founder and Head of Clinical Development of Sen-Jam Pharmaceutical. T.A.D. is the partner and Head of Product Development and Regulatory Affairs of Sen-Jam Pharmaceutical. The independent studies were conducted by Calvert Laboratories, Inc, without involvement of the authors and the funder. The funder was involved in the design of the studies, interpretation of data, writing of the manuscript, and in the decision to publish the results.